Rosenblatt Maintains Buy on Dolby Laboratories, Maintains $98 Price Target

Dolby Laboratories, Inc. Class A -2.35%

Dolby Laboratories, Inc. Class A

DLB

78.90

-2.35%

Rosenblatt analyst Steve Frankel maintains Dolby Laboratories (NYSE: DLB) with a Buy and maintains $98 price target.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via